Non-use of primary care routine consultations for individuals with hypertension

The objectives of this study were to identify, among individuals with hypertension, sociodemographic factors associated with non-use of routine medical appointments available in primary care and check if non-use of consultations interferes with noncompliance with pharmacotherapy, uncontrolled blood pressure and hospitalization. This is a cross-sectional study with random and stratified sampling. A total of 422 individuals living in the city of Maring á, Paraná, were interviewed. There were crude and adjusted analyses using logistic regression, estimating odds ratios and 95% confidence intervals. It was found that, in the six months preceding the interview, 47 (11.1%) individuals did not use routine appointments. Being male, nonwhite and using only public health services were associated with non-use of consultations. Most of those who did not use consultations also failed to comply with pharmacotherapy and presented dysregulated blood pressure. Healthcare professionals need to develop strategies in order to increase attendance of hyperten sive individuals to medical appointments, giving priority to population groups of men, nonwhite individuals and those who use public health services. Greater use of consultations can assist in blood pressure control and reduce complications.
Source: Ciencia e Saude Coletiva - Category: Occupational Health Source Type: research

Related Links:

Authors: Parent F, Sanchez O, groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE PMID: 31611022 [PubMed - as supplied by publisher]
Source: Revue des Maladies Respiratoires - Category: Respiratory Medicine Tags: Rev Mal Respir Source Type: research
Conclusions: Adopting a pharmacist-involved team-based hypertension model could substantially improve BP control and cardiovascular outcomes in the United States. Net cost-savings among groups 2 and 3 make a compelling case for Medicare, but favorable economics may also be possible for private insurers, particularly if innovations could moderately lower the cost of delivering an effective intervention.
Source: Medical Care - Category: Health Management Tags: Original Articles Source Type: research
Publication date: Available online 15 October 2019Source: Urology Case ReportsAuthor(s): Akito Ito, Mizuki Hisano, Makoto Takahashi, Naoki Komine, Takaya Abe, Wataru ObaraAbstractA 73-year-old-male patient with hypertension and grade 3B chronic kidney disease underwent radical nephrectomy in the year 2000. As the renal function gradually worsened, the patient was started on hemodialysis in 2003. Eleven years after nephrectomy, the metastases were pointed out. The patient received sunitinib as first-line therapy. Thereafter, as the metastatic lesions became larger, we initiated nivolumab therapy (3 mg/m2 every 2 weeks). Aft...
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
Authors: Muñoz Morales A, Sánchez-Vicente JL, Franco Ruedas C, de Las Morenas Iglesias J, Espiñeira Periñán MÁ, López-Herrero F Abstract A 36 year-old woman with idiopathic intracranial hypertension was treated with topiramate and acetazolamide. The patient was followed-up for 2 years, with a relationship between neurosensory detachments and topiramate being established, with recurrences after the introduction of topiramato and improvement after its withdrawal. These findings point topiramate as a possible cause of the clinical picture. Topiramate may cause retinal a...
Source: Archivos de la Sociedad Espanola de Oftalmologia - Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research
Conclusions: Inadequate emergence in PACU following general anesthesia is a significant problem that is correlated with several perioperative factors. It seems that patients with a history of substance dependence are more at the risk of inadequate emergence than normal population. PMID: 31612693 [PubMed - as supplied by publisher]
Source: Korean Journal of Anesthesiology - Category: Anesthesiology Tags: Korean J Anesthesiol Source Type: research
Do obese individuals with NAFLD who are"metabolically healthy" (i.e., without diabetes, hypertension or high lipid levels) differ in fibrosis progression versus those with these risk factors?Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
HIGH blood pressure can be life-threatening if left untreated. Fortunately, making simple dietary changes can keep the risks at bay. A certain superfood has been shown to lower a person ’s reading.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Large artery stiffening is widely believed to be the primary driver of isolated systolic hypertension and is recognised as a major cardiovascular risk factor [1]. Since arterial stiffness modulates the speed at which blood pressure waves propagate along arteries, and since the greatest loss of arterial compliance with ageing occurs in the aorta, the most popular surrogate index of arterial stiffness is carotid-femoral pulse wave velocity (cf-PWV) [1 –4]. This is estimated by measuring the time delay between carotid and femoral arterial pulses and the length between these sites.
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Editorial Source Type: research
Hereby, we would like to submit our response to the Letter to the Editor concerning our manuscript entitled “Analysis of novel cardiovascular biomarkers in patients with pulmonary hypertension (PH)” [1]. We will discuss the comments by the readers below:
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Letter to the Editor Source Type: research
Authors: Cruz FF, Rocco PRM Abstract Introduction: Mesenchymal stem/stromal cells (MSCs) have been shown to improve lung function and survival in chronic inflammatory lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension (PAH), and silicosis. Areas covered: This review covers rationale for the use of MSC therapy, along with preclinical studies and clinical trials with MSC therapy in chronic lung diseases. Expert opinion: MSC therapy holds promise for the treatment of chronic lung diseases, mainly when administered at early...
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Tags: Expert Rev Respir Med Source Type: research
More News: Hypertension | International Medicine & Public Health | Primary Care | Study